North America Clinical Trials Market 2021-2031

Bonafide Trust 03-04-2022 136 Pages
Region : North America Category : Lifescience Medical Devices

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in new 100 days, get it free!

Report Description
Table of Contents
List of Figure Tables

North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $ 39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments. Highlighted with 29 tables and 75 figures, this 136-page report “North America Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country. Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Trials of Drugs o Small Molecule Drugs o Vaccines o Cell & Gene Therapy o Other Drugs • Trials of Devices • Trials of Procedures Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Phase I • Phase II • Phase III • Phase IV By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Interventional Studies o Randomized Control Trial o Adaptive Clinical Trial o Non-randomized Control Trial • Observational Studies o Cohort Study o Case Control Study o Cross Sectional Study o Ecological Study • Expanded Access Trials By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Protocol Designing • Site Identification • Patient Recruitment • Laboratory Services • Bioanalytical Testing Services • Clinical Trial Data Management Services • Clinical Trial Supply & Logistic Services • Decentralized Clinical Trial Services • Medical Device Testing Services • Other Clinical Trial Services By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Infectious Diseases • Cardiology • Obesity • Diabetes • Neurology • Immunology • Pain Management • Other Indications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical and Biotechnological Companies • Clinical Research Organizations • Clinical Testing Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Accell Clinical Research LLC Charles River Laboratory ClinDatrix Inc Clinipace Eli Lilly and Company F. Hoffmann-La Roche Ltd. ICON PLC IQVIA Holdings, Inc. Laboratory Corporation of America Novo Nordisk AS PAREXEL International Corporation Pfizer Inc. Pharmaceutical Product Development LLC PRA Health Sciences Sanofi SA SGS SA Syneos Health Inc. Wuxi AppTec Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 33

2.4 Emerging Opportunities and Market Trends 36

2.5 Porter’s Fiver Forces Analysis 40

3 Segmentation of North America Market by Product Category 44

3.1 Market Overview by Product Category 44

3.2 Trials of Drugs 46

3.2.1 Small Molecule Drugs 47

3.2.2 Vaccines 48

3.2.3 Cell & Gene Therapy 49

3.2.4 Other Drugs 50

3.3 Trials of Devices 51

3.4 Trials of Procedures 52

4 Segmentation of North America Market by Phase 53

4.1 Market Overview by Phase 53

4.2 Phase I 55

4.3 Phase II 56

4.4 Phase III 57

4.5 Phase IV 58

5 Segmentation of North America Market by Design 59

5.1 Market Overview by Design 59

5.2 Interventional Studies 61

5.2.1 Randomized Control Trial 63

5.2.2 Adaptive Clinical Trial 64

5.2.3 Non-randomized Control Trial 65

5.3 Observational Studies 66

5.3.1 Cohort Study 68

5.3.2 Case Control Study 69

5.3.3 Cross Sectional Study 70

5.3.4 Ecological Study 71

5.4 Expanded Access Trials 72

6 Segmentation of North America Market by Service Type 73

6.1 Market Overview by Service Type 73

6.2 Protocol Designing 75

6.3 Site Identification 76

6.4 Patient Recruitment 77

6.5 Laboratory Services 78

6.6 Bioanalytical Testing Services 79

6.7 Clinical Trial Data Management Services 80

6.8 Clinical Trial Supply & Logistic Services 81

6.9 Decentralized Clinical Trial Services 82

6.10 Medical Device Testing Services 83

6.11 Other Clinical Trial Services 84

7 Segmentation of North America Market by Indication 85

7.1 Market Overview by Indication 85

7.2 Oncology 87

7.3 Infectious Diseases 88

7.4 Cardiology 89

7.5 Obesity 90

7.6 Diabetes 91

7.7 Neurology 92

7.8 Immunology 93

7.9 Pain Management 94

7.10 Other Indications 95

8 Segmentation of North America Market by End User 96

8.1 Market Overview by End User 96

8.2 Pharmaceutical and Biotechnological Companies 98

8.3 Clinical Research Organizations 99

8.4 Clinical Testing Laboratories 100

8.5 Other End Users 101

9 North America Market 2021-2031 by Country 102

9.1 Overview of North America Market 102

9.2 U.S. 105

9.3 Canada 108

9.4 Mexico 110

10 Competitive Landscape 112

10.1 Overview of Key Vendors 112

10.2 New Product Launch, Partnership, Investment, and M&A 116

10.3 Company Profiles 117

Accell Clinical Research LLC 117

Charles River Laboratory 119

ClinDatrix Inc 120

Clinipace 121

Eli Lilly and Company 122

F. Hoffmann-La Roche Ltd. 123

ICON PLC 124

IQVIA Holdings, Inc. 125

Laboratory Corporation of America 126

Novo Nordisk AS 127

PAREXEL International Corporation 128

Pfizer Inc. 129

Pharmaceutical Product Development LLC 130

PRA Health Sciences 131

Sanofi SA 132

SGS SA 133

Syneos Health Inc. 134

Wuxi AppTec Inc. 135

RELATED REPORTS 136

List of Tables:

Table 1. Snapshot of North America Clinical Trials Market in Balanced Perspective, 2021-2031 18
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021 21
Table 3. World Economic Outlook, 2021-2031 23
Table 4. World Health Spending by Region, $ bn, 2013-2020 32
Table 5. Main Product Trends and Market Opportunities in North America Clinical Trials Market 36
Table 6. North America Clinical Trials Market by Product Category, 2021-2031, $ mn 44
Table 7. North America Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn 46
Table 8. North America Clinical Trials Market by Phase, 2021-2031, $ mn 53
Table 9. North America Clinical Trials Market by Design, 2021-2031, $ mn 59
Table 10. North America Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn 62
Table 11. North America Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn 67
Table 12. North America Clinical Trials Market by Service Type, 2021-2031, $ mn 73
Table 13. North America Clinical Trials Market by Indication, 2021-2031, $ mn 85
Table 14. North America Clinical Trials Market by End User, 2021-2031, $ mn 96
Table 15. North America Clinical Trials Market by Country, 2021-2031, $ mn 103
Table 16. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn 107
Table 17. U.S. Clinical Trials Market by Design, 2021-2031, $ mn 107
Table 18. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn 107
Table 19. Canada Clinical Trials Market by Phase, 2021-2031, $ mn 109
Table 20. Canada Clinical Trials Market by Design, 2021-2031, $ mn 109
Table 21. Canada Clinical Trials Market by Indication, 2021-2031, $ mn 109
Table 22. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn 111
Table 23. Mexico Clinical Trials Market by Design, 2021-2031, $ mn 111
Table 24. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn 111
Table 25. Percentage of Registered Studies by Location (as of February 24, 2022) 114
Table 26. Percentage of Recruiting Studies by Location (as of February 24, 2022) 114
Table 27. Accell Clinical Research LLC: Company Snapshot 117
Table 28. Accell Clinical Research LLC: Business Segmentation 118
Table 29. Accell Clinical Research LLC: Product Portfolio 118

List of Figures:

Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Clinical Trials Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America Clinical Trials Market 26
Figure 7. Percentage of Trial Participants by Country, 2015-2019 29
Figure 8. Leading Causes of Death in the World, 2019-2020, million 30
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 11. Primary Restraints and Impact Factors of North America Clinical Trials Market 33
Figure 12. Investment Opportunity Analysis 37
Figure 13. Porter’s Fiver Forces Analysis of North America Clinical Trials Market 40
Figure 14. Breakdown of North America Clinical Trials Market by Product Category, 2021-2031, % of Revenue 45
Figure 15. North America Addressable Market Cap in 2022-2031 by Product Category, Value ($ mn) and Share (%) 45
Figure 16. North America Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn 46
Figure 17. North America Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn 47
Figure 18. North America Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn 48
Figure 19. North America Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn 49
Figure 20. North America Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn 50
Figure 21. North America Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn 51
Figure 22. North America Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn 52
Figure 23. Breakdown of North America Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue 54
Figure 24. North America Addressable Market Cap in 2022-2031 by Phase, Value ($ mn) and Share (%) 54
Figure 25. North America Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn 55
Figure 26. North America Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn 56
Figure 27. North America Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn 57
Figure 28. North America Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn 58
Figure 29. Breakdown of North America Clinical Trials Market by Design, 2021-2031, % of Sales Revenue 60
Figure 30. North America Addressable Market Cap in 2022-2031 by Design, Value ($ mn) and Share (%) 60
Figure 31. North America Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn 61
Figure 32. North America Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn 63
Figure 33. North America Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn 64
Figure 34. North America Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn 65
Figure 35. North America Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn 66
Figure 36. North America Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn 68
Figure 37. North America Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn 69
Figure 38. North America Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn 70
Figure 39. North America Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn 71
Figure 40. North America Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn 72
Figure 41. Breakdown of North America Clinical Trials Market by Service Type, 2021-2031, % of Revenue 74
Figure 42. North America Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 74
Figure 43. North America Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn 75
Figure 44. North America Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn 76
Figure 45. North America Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn 77
Figure 46. North America Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn 78
Figure 47. North America Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn 79
Figure 48. North America Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn 80
Figure 49. North America Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn 81
Figure 50. North America Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn 82
Figure 51. North America Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn 83
Figure 52. North America Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn 84
Figure 53. Breakdown of North America Clinical Trials Market by Indication, 2021-2031, % of Revenue 86
Figure 54. North America Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 86
Figure 55. North America Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn 87
Figure 56. North America Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn 88
Figure 57. North America Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn 89
Figure 58. North America Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn 90
Figure 59. North America Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn 91
Figure 60. North America Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn 92
Figure 61. North America Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn 93
Figure 62. North America Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn 94
Figure 63. North America Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn 95
Figure 64. Breakdown of North America Clinical Trials Market by End User, 2021-2031, % of Revenue 96
Figure 65. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 97
Figure 66. North America Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn 98
Figure 67. North America Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn 99
Figure 68. North America Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn 100
Figure 69. North America Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn 101
Figure 70. Breakdown of North America Clinical Trials Market by Country, 2021 and 2031, % of Revenue 103
Figure 71. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 104
Figure 72. U.S. Clinical Trials Market, 2021-2031, $ mn 106
Figure 73. Canada Clinical Trials Market, 2021-2031, $ mn 108
Figure 74. Clinical Trials Market in Mexico, 2021-2031, $ mn 110
Figure 75. Growth Stage of North America Clinical Trials Industry over the Forecast Period 112

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3200
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

North America Clinical Trials Market 2021-2031

North America Clinical Trials Market 2021-2031